Leukemia Screening Market,By Test Type (Complete Blood Count (CBC), Bone Marrow Aspiration and Biopsy, Flow Cytometry, Cytogenetic Analysis, Polymerase Chain Reaction (PCR), Immunophenotyping, Others)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	June, 2023	CMI18049164

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049164

Leukemia Screening Market,By Test Type (Complete Blood Count (CBC), Bone Marrow Aspiration and Biopsy, Flow Cytometry, Cytogenetic Analysis, Polymerase Chain Reaction (PCR), Immunophenotyping, Others), By Disease Type (Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia (CML), Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Others), By Age Group (Pediatric Leukemia Screening, Adult Leukemia Screening, Geriatric Leukemia Screening), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test.

Market Dynamics:

Increasing incidence of hematologic cancer, growing demand for personalized therapy, and growing emphasis on patient-centric care are some of the key factor augmenting leukemia screening market growth. The aging population, increasing awareness about early screening, and rapid advancements in the field of hematology are also expected to boost the market growth. However, lack of accurate diagnostics, high cost of advanced tests, and stringent government regulations are some of the major challenges faced by the hematology test industry. In addition, a shortage of skilled labor and lack of standardization in test procedures are also limiting the growth of leukemia screen market.

Key features of the study:

This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global leukemia screening market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Illumina, Inc., QIAGEN N.V., Grifols, S.A., Siemens Healthineers AG, Agilent Technologies, Inc., Ortho Clinical Diagnostics, Biocept, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market

Detailed Segmentation:

Global Leukemia Screening Market, By Test Type

Complete Blood Count (CBC)

Bone Marrow Aspiration and Biopsy

Flow Cytometry

Cytogenetic Analysis

Polymerase Chain Reaction (PCR)

Immunophenotyping

Others

Global Leukemia Screening Market, By Disease Type

Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Chronic Lymphocytic Leukemia (CLL)

Chronic Myeloid Leukemia (CML)

Others

Global Leukemia Screening Market, By End User

Hospitals and Clinics

Diagnostic Laboratories

Research Institutes

Others

Global Leukemia Screening Market, Age Group

Pediatric Leukemia Screening

Adult Leukemia Screening

Geriatric Leukemia Screening

Global Leukemia Screening Market, By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Key Players

Hoffmann-La Roche Ltd

Abbott Laboratories

Thermo Fisher Scientific Inc.

Sysmex Corporation

Bio-Rad Laboratories, Inc.

Illumina, Inc.

QIAGEN N.V.

Grifols, S.A.

Siemens Healthineers AG

Agilent Technologies, Inc.

Ortho Clinical Diagnostics

Biocept, Inc.

Adaptive Biotechnologies Corporation

Invivoscribe, Inc.

ArcherDX, Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Test Type; Market Snapshot, By Disease Type; Market Snapshot, By End User; Market Snapshot, By Age Group; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing incidence of hematologic cancer; High cost of advanced tests; Rapid advancements in the field of hematology; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Leukemia Screening Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Leukemia Screening Market , By Test Type, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Complete Blood Count (CBC); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Bone Marrow Aspiration and Biopsy; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Flow Cytometry; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Cytogenetic Analysis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Polymerase Chain Reaction (PCR); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Immunophenotyping; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Leukemia Screening Market , By Disease Type, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Acute Lymphoblastic Leukemia (ALL); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Acute Myeloid Leukemia (AML); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Chronic Lymphocytic Leukemia (CLL); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Chronic Myeloid Leukemia (CML); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Leukemia Screening Market , By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Diagnostic Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research Institutes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Leukemia Screening Market , By Age Group, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Pediatric Leukemia Screening; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Adult Leukemia Screening; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Geriatric Leukemia Screening; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Global Leukemia Screening Market , By Region, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018–2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn); 10. Competitive Landscape; F.Hoffmann-La Roche Ltd; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Abbott Laboratories; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Thermo Fisher Scientific Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Sysmex Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bio-Rad Laboratories, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Illumina, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; QIAGEN N.V.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Grifols, S.A.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Siemens Healthineers AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Agilent Technologies, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Ortho Clinical Diagnostics; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Biocept, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Adaptive Biotechnologies Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Invivoscribe, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; ArcherDX, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Analyst Views; 11. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Leukemia Screening Market” - Global forecast to 2030